<DOC>
	<DOCNO>NCT02434133</DOCNO>
	<brief_summary>The investigator propose study first kind . The investigator measure measles , mumps , rubella , tetanus , diphtheria pertussis antibodies patient current IBD treatment modality compare vaccine antibody concentration correlate time since immunization .</brief_summary>
	<brief_title>Cross Sectional Study Vaccine Antibody Response Inflammatory Bowel Disease Patients</brief_title>
	<detailed_description>Tetanus diphtheria become rare disease widespread immunization begin World War II . The percentage people get pertussis ( whooping cough ) also go vaccination , large outbreak occur past decade . Measles , mumps , rubella ( German measles ) varicella ( chicken pox ) illnesses resolve quickly , cause disease take hold get bad . Routine vaccination prevent infection recommend use United States begin 1960s 1970s ; 1995 varicella . Today measles , mumps , rubella especially uncommon U.S. thanks vaccination program ; percentage people varicella go . Despite widespread vaccination effort , recent outbreak measles mumps U.S. , part disease still common part world . Inflammatory bowel disease ( IBD ) chronic inflammatory disorder gastrointestinal tract include Crohn 's disease ( CD ) ulcerative colitis ( UC ) . Treatment option IBD consist immunosuppressive therapy , mean drug weaken immune system , systemic corticosteroid , immunomodulators ( thiopurines methotrexate ) and/or biologics , tumor necrosis factor alpha ( TNF ) agent integrin inhibitor ( vedolizumab ) . Patients IBD achieve clinical remission decrease risk complication treatment ; however , treatment also increase risk infection weaken immune system . Some infection preventable routine vaccination . You invite take part research project determine people IBD different type therapy low amount antibody healthy individual . Antibodies proteins use immune system attack virus like tetanus measles . Antibodies introduce body vaccine . The few antibody , hard antibody attack virus , mean person could get sick virus . This research project help u figure whether people IBD few antibody people without IBD . The investigator also look whether type treatment people take IBD affect amount antibody . T This tell u likely get sick virus , . The investigator recruit 90 IBD patient treatment IBD well 20 healthy control total 110 patient University Wisconsin Hospital &amp; Clinics .</detailed_description>
	<mesh_term>Intestinal Diseases</mesh_term>
	<mesh_term>Inflammatory Bowel Diseases</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>Inclusion Criteria A history chronic ( great 3 month ) ulcerative colitis Crohn 's disease diagnose documented standard clinical , radiographic , endoscopic histopathologic criterion . Undergoing blood work day study visit routine blood monitoring due medication . Has document tetanusdiphtheria ( Td ) tetanusdiphtheriaacellular pertussis ( Tdap ) Wisconsin Immunization Registry ( WIR ) least 4 week prior enter study . Has document measles , mumps rubella ( MMR ) Wisconsin Immunization Registry ( WIR ) least 4 week prior enter study . This need meet 50 % patient group AC . Is currently take one follow medication regimen least 3 month . Group A ( Immunomodulator ) currently take azathioprine 6 mercaptopurine Group B ( Biologic group ) currently take antiTNF therapy ( infliximab , golimumab , adalimumab , certolizumab ) . Group C ( Combination therapy ) currently take antiTNF therapy immunomodulator ( include methotrexate ) The patient must understand voluntarily sign informed consent document . Exclusion Criteria Unconfirmed Td Tdap vaccination status Patients venipuncture feasible due poor tolerability lack easy access . CONTROLS Inclusion Criteria Has document tetanusdiphtheria ( Td ) tetanusdiphtheriaacellular pertussis ( Tdap ) Wisconsin Immunization Registry ( WIR ) least 4 week prior enter study . Has document measles , mumps rubella ( MMR ) least two injection Wisconsin Immunization Registry ( WIR ) least 4 week prior enter study . CONTROLS Exclusion Criteria Currently immunosuppressive therapy Has chronic health condition may impact vaccine antibody concentration deem investigator , include chronic liver disease , celiac disease , history solid organ bone marrow transplantation . Older age 65 year Unconfirmed MMR vaccination status Patients venipuncture feasible due poor tolerability lack easy access .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>